Projeler
1. Immunomodulatory and anticancer effects of different carbon nanoparticles and new bacteriophage strains isolated from nature, BAP, Project Number: 2017-2-AP4-2506, 30000 TL, Manager, 2020,Completed.
2. Investigation of antioxidant and antimicrobial activity of extracts from Alyssum floribundum Boiss. & Balansa (Brassicaceae) plants, BAP, Project Number: 2017-2-TP2-2531, 11000 TL, Manager, 2018,Completed.
3. An Investigation of the Cytotoxic Effect of Fulvestrant on hERG1 Potassium Channel Gene Expression in MCF-7 Breast Cancer Cell Culture., BAP, Project Number: 2017-2-AP3-2645, 15000 TL, Manager, 2018,Completed.
4. The investigation of Tozasertib, An Aurora Kinase Inhibitor, and Vitamin-D3 on to the CPC (Chromosomal Passanger Complex) Pathway in Leukemic Cells, BAP, Project Number: 2016-1-TP2-1415, 11000 TL, Manager, 2018,Completed.
5. investigation of the Biological Effect of Extracts Obtained from Onosma mutabilis boiss. (Boraginaceae) Plant on the DU145 Prostate Cancer Cell Line , BAP, Project Number: 2017-1-TP2-2265, 6902 TL, Manager, 2018,Completed.
6. THE INVESTIGATION OF THE EFFECT OF DANUSERTIB, A PAN-AURORA KINASE INHIBITOR, ONTO AUTOPHAGY, METASTASİS AND EPİTHELİAL MESENCHYMAL TRANSİTİON (EMT) IN PANCREATIC CANCER CELLS, BAP, Project Number: 2017-1-TP2-2254, 10995 EUR, Manager, 2018,Completed.
7. THE INVESTIGATION OF THE EFFECT OF DANUSERTIB, A PAN-AURORA KINASE INHIBITOR, ONTO CYTOTOXICITY, CELL CYCLE AND APOPTOSIS IN PANCREATIC CANCER CELLS , BAP, Project Number: 2017-1-TP2-2252, 10996 EUR, Manager, 2018,Completed.
8. In Vitro Investigation of Anticancer Effects of Arum dioscoridis Plant Extracts with the Tozasertib onto the CFPAC-1 Pancreatic Carcinoma Cell Line, BAP, Project Number: 2016-1-TP3-1414, 20900 TL, Manager, 2017,Completed.
9. Aurora Kinaz B İnhibitörü Tozasertib ve Metilprednizolon birlikteliğinin lösemik hücrelerde CPC (Chromosomal Passanger Complex) Yolağı Üzerindeki Etkilerinin Araştırılması, BAP, Project Number: 2015-TP2-1177, 7000 TL, Manager, 2017,Completed.
10. İncidence of euthyroid sick syndrome in pediatric oncology departments childs, BAP, Project Number: 2016-1-TP3-1432, 5000 TL, Manager, 2017,Completed.
11. The investigation of the effect of tozasertibe, a Aurora Kinase-B inhibitor, onto the Chromosomal Passanger Complex (CPC) pathway in Pancreatic Carcinoma Cells., BAP, Project Number: MEÜ BAP-FBE BB(HÇ) 2014-1YL, 10000 TL, Manager, 2015,Completed.
12. The investigation of effect of Fasudil (HA-1077), a Rho kinase inhibitor, onto the relation of cytotoxicity, apoptosis and metastasis in pankreatic carcinoma cells (BxPC-3), BAP, Project Number: MEÜ-BAP-FBE BB (CK) 2012-4 YL, 10000 TL, Manager, 2015,Completed.
13. The investigation of gene expressions of Supressor of the Cytokine Signalling in methylprednisolone and vitamin-D3 treatment chronic myeloblastic leukemia (K-562) cells, BAP, Project Number: MEÜ-BAP BB(BM) 2009-7 YL , 7000 TL, Manager, 2011,Completed.
14. The synergistic effect of Metilprednizolon and Vitamine-D3 onto the DR-nm23 gene expression, apoptosis and differentiation in leukemic cells, BAP, Project Number: ”. MEÜ-BAP FEF(AAÖ) 2007-1, 10000 TL, Manager, 2008,Completed.
15. Kalkon-İzooksazol Hibrit Bileşiklerinin Sentezi ve Antikanser Özelliklerinin Araştırılması, Tübitak-1002, Project Number: 119S045, 30 TL, Researcher, 2020,Completed.
16. An Investigation of the Cytotoxic Effect of Fulvestrant on hERG1 Potassium Channel Gene Expression in MCF-7 Breast Cancer Cell Culture., BAP, Project Number: 2017-2-AP3-2645, 15000 TL, Researcher, 2018,Completed.
17. Investigation of Radiosensitive Role of Imipramine in Prostate Cancer Cells with Radiotherapy, BAP, Project Number: 2017-2-AP4-2537, 29211 EUR, Researcher, 2018,Completed.
18. The investigation of the expression levels of miRNA processing genes DICER, DROSHA, XPO5, DGCR8, TARP2, AGO1 ve AGO2 in hematologic malignancies, BAP, Project Number: 2015-TP3-1205, 18000 TL, Researcher, 2018,Completed.
19. The Investigation of TamoxifenandVitamin D Combination ofApoptosisand Cell CycleEffectsin BreastCancer Cell Line, BAP, Project Number: 2015-TP3-1293, 21000 TL, Researcher, 2018,Completed.
20. The electrophysiological effects of Astemizole and Imipramine on Eag1 channels in DU-145 cell lines, BAP, Project Number: 2015-TP2-1188, 7360 TL, Researcher, 2017,Completed.
21. İnvestigation of sox-2 and B-katenin expression for diagnosis in adenoma-carcinoma sequence of colon polyps, BAP, Project Number: 2015-TP3-1254, 14332 TL, Researcher, 2016,Completed.
22. Aurora Kinase B Tozasertib Pancreatic Carcinoma Cell Investigation of the effect onCPCI Pathway Inhibitor , BAP, Project Number: BAP-FBE-BB(CK) 2014-1YL, 986600 TL, Researcher, 2015,Completed.
23. The investigation of Doxorubicin’s anti-cancer effects on pancreas carcionoma (BxPC-3) cell line, BAP, Project Number: MEÜ BAP-FBE BB(TY) 2013-4 YL, 10000 TL, Researcher, 2014,Completed.
24. Investigation of Doxorubin the Anticancer Effect of pancreatic carcinoma cell line, BAP, Project Number: BAP-FBE BB (TY) 2013-4 YL, 999700 TL, Researcher, 2014,Completed.
25. The determination of DR-nm23 gene expression level in Acute Myeloid Leukemia patients treatment with high dose methylprednisolone (HDMP), HUBAP, Project Number: HÜ-BAP 01 02 101 022, 28000 TL, Researcher, 2008,Completed.
26. Rho Kinaz ve Siklooksijenaz İnhibitörleri ile Siklofosfamid Kombinasyonlarının Çeşitli Tümör Hücre Serilerine Etkileri, BAP, Project Number: TF-TTB-NAA-2006-1, 30000 TL, Researcher, 2008,Completed.
27. The effects of Rho-kinase and cyclooxigenase inhibitors with cyclophosphamide combinations onto the range of tumor cell lines, BAP, Project Number: MEÜ-BAP SBE TTB (ED) 2006-1 DR, 5000 TL, Researcher, 2007,Completed.
28. The investigation of the effect of Acetylsalicilic acide (aspirine) and Rho-kinase Y-27632 combinations onto the human neuroblastoma and leukemia cell line, BAP, Project Number: MEÜ-BAP TF TTB (NAA) 2006-1, 40000 TL, Researcher, 2007,Completed.
29. The effect of steroid on DR-nm23 gene expression, apoptosis and differentiation in human acute myeloid leukemia (HL-60) cell line, TÜBİTAK, Project Number: TÜBİTAK SBAG- 2515 (101S215), 10000 TL, Researcher, 2005,Completed.